The hiPSC lines described here can support fundamental research on variant- and patient-specific disease mechanisms, aberrant downstream signaling and alterations in osteogenic differentiation in FGFR2-related craniosynostosis. The gene discussed is FGFR2; the disease is craniosynostosis.